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Abstract
Background and Aims: Recent studies have shown that activated pancreatic stellate cells (PSCs) play a major role in
pancreatic fibrogenesis. We aimed to study the effect of L-cysteine administration on fibrosis in chronic pancreatitis (CP)
induced by trinitrobenzene sulfonic acid (TNBS) in rats and on the function of cultured PSCs.
Methods: CP was induced by TNBS infusion into rat pancreatic ducts. L-cysteine was administrated for the duration of the
experiment. Histological analysis and the contents of hydroxyproline were used to evaluate pancreatic damage and fibrosis.
Immunohistochemical analysis of a-SMA in the pancreas was performed to detect the activation of PSCs in vivo. The
collagen deposition related proteins and cytokines were determined by western blot analysis. DNA synthesis of cultured
PSCs was evaluated by BrdU incorporation. We also evaluated the effect of L-cysteine on the cell cycle and cell activation by
flow cytometry and immunocytochemistry. The expression of PDGFRb, TGFbRII, collagen 1a1 and a-SMA of PSCs treated
with different concentrations of L-cysteine was determined by western blot. Parameters of oxidant stress were evaluated in
vitro and in vivo. Nrf2, NQO1, HO-1, IL-1b expression were evaluated in pancreas tissues by qRT-PCR.
Results: The inhibition of pancreatic fibrosis by L-cysteine was confirmed by histological observation and hydroxyproline
assay. a-SMA, TIMP1, IL-1b and TGF-b1 production decreased compared with the untreated group along with an increase in
MMP2 production. L-cysteine suppressed the proliferation and extracellular matrix production of PSCs through down-
regulating of PDGFRb and TGFbRII. Concentrations of MDA+4-HNE were decreased by L-cysteine administration along with
an increase in GSH levels both in tissues and cells. In addition, L-cysteine increased the mRNA expression of Nrf2, NQO1 and
HO-1 and reduced the expression of IL-1b in L-cysteine treated group when compared with control group.
Conclusion: L-cysteine treatment attenuated pancreatic fibrosis in chronic pancreatitis in rats.
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Introduction
Chronic pancreatitis (CP) is characterized by progressive fibrosis
and pain and/or loss of exocrine and endocrine functions [1,2].
Conservative modalities include analgesics, anti-secretory therapy
withH2 receptor blockers or proton pump inhibitors and pancreatic
enzyme supplementation. However, clinical studies including ran-
domized control trials have shown divergent results questioning the
efficacy of these modalities [3]. Also, on the interventional front
(endotherapy [4], celiac plexus neurolysis and block [5],and surgery
[6]), there is a paucity of convincing efficacy data. Studies have also
shown that high-dose naproxen, which is orally used for the
treatmentofpain,canaggravatepancreaticfibrosis ina ratmodelof
chronic pancreatitis [7].
Currently, numerous in vivo and in vitro studies have provided
strong evidence for a pivotal role for pancreatic stellate cells (PSCs)
infibrogenesisassociatedwithacuteandchronicpancreatitis[8–11].
In addition to the elimination of the conditions inducing acinar cell
injury (e.g., alcohol) and the reduction of the inflammatory response
of the host, therapeutic targeting of PSCs may represent a promising
new strategy for reducing fibrogenesis. Pharmacological agents have
been developed to inhibit the activation and functions of PSCs such
as anti-inflammatory and immunomodulatory compounds, antiox-
idant compounds, protease inhibitors and the HMG-CoA reductase
inhibitor [12].
Oxidative stress is an important stimulus of PSCs activation
[13]. In cell culture experiments, it has been shown that rat
PSCs are activated in response to ethanol per se, mediated by the
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such as iron sulphate/ascorbic acid (which increases oxidant stress
within PSCs) leads to PSCs’ activation [14]. Therefore, antioxi-
dant activity is effective for anti-fibrogenesis.
L-cysteine, the limiting amino acid for glutathione (GSH) syn-
thesis [15], is a sulfur-containing amino acid and plays an important
role as an extracellular reducing agent. In vitro studies have shown
that antioxidants, such as N-acetylcysteine and vitamin E, can
prevent oxidant stress or ethanol-induced PSCs activation [16,17].
We hypothesize that L-cysteine, as an anti-oxidant compound, may
prevent pancreatic fibrosis and inhibit PSCs activation. We
therefore evaluated the effect of L-cysteine in vivo and in vitro,
determining whether it was effective in preventing the development
of pancreatic fibrosis induced by trinitrobenzene sulfonic acid
(TNBS) in a rat model via its effect on PSCs. Here we report the
antifibrotic effect of L-cysteine in chronic pancreatitis induced by
TNBS administration in rats.
Materials and Methods
Ethics statement
All the animal related procedures were approved by the Animal
Care and Use Committee of The Tenth People’s Hospital of
Shanghai. Permit number: 2011-RES1. This study was also
approved by Science and Technology Commission of Shanghai
Municipality (ID: SYXK 2007-0006). The rats were kept at 18uC–
26uC on a 12 hours light and dark cycle with free access to water
and standard rat chow. They were allowed to acclimatize for
a minimum of 1 week. The environment was maintained at a
relative humidity of 30%–70%.
Animals and experimental protocol
One-month-old male Sprague Dawley (SD) rats (50 g–80 g)
were purchased from Shanghai SLAC Laboratory Animal Co Ltd
(Shanghai, China). Rats were randomly assigned to four groups of
10 animals each (Figure 1). In this study, group b and group d rats
were fed with rat chow containing 2% L-cysteine (Sigma-Aldrich,
St. Louis, Missouri, USA) for the duration of the experiment,
according to a protocol established by Horie et al. [18], and group
a and group c rats were given normal chow without L-cysteine.
One month after the initiation of the diet, group a and group b
rats were given sham operations, and group c and group d rats
were induced in the experimental model of chronic pancreatitis as
previously described [19]. Briefly, the main pancreatic duct of
anesthetized rats, using 3% pentobarbital sodium, was cannulated
through the papilla using polyethylene tubing (PE 5.0). The
duct was tied close to the liver and 0.4 ml of 2% TNBS (Sigma-
Aldrich, St. Louis, Missouri, USA) solution (in 10% ethanol in
phosphate-buffered saline (PBS, PH 7.4)) was intraductally infused
until completion. Total exposure time to TNBS was 40 minutes
followed by a washout period of 30 minutes. Ligatures were then
released and the duodenum and the abdominal wall were sutured.
28 days after TNBS injection, rats were killed under anesthesia
with 3% pentobarbital sodium and each pancreas was quickly
removed and weighed, fixed in 4% paraformaldehyde buffered
with PBS overnight at 4uC, and embedded in paraffin wax or
frozen immediately at 280uC. Whole-blood samples were kept at
room temperature for 2 hours before centrifugation for 20 min-
utes at ,20006g, and serum was stored at 280uC for further
studies. Dead rats were replaced with new ones to maintain 10
animals in each group.
Serum amylase and lipase assay
The serum activities of amylase and lipase were measured by
enzyme dynamics chemistry using commercial kits according to the
manufacturer’s protocols in a Roche/Hitachi modular analytics
system (Roche, Mannheim, Germany).
Histological examination
For light microscopy, haematoxylin-eosin (H&E) staining and
Masson’s trichrome staining were done according to standard
procedures. All specimens were scored by 2 pathologists who were
unaware of the origin of the specimens. Evaluation of the pancreas
was performed according to Puig-Divi et al. [20]. Three pancreas
sections were randomly selected and scored from each rat. Median
scores were calculated to morphologically assess tissue damage.
Briefly, a semi-quantitative score was used that graded glandular
atrophy (0–3), intralobular, interlobular and periductal fibrosis (0–
3) and inflammatory mononuclear infiltrates (0–3). A damage
index (DI) was established.
Immunohistochemical study of alpha-smooth muscle
actin (a-SMA)
Tissue block sections were mounted on slides, deparaffinized
in xylene and rehydrated in alcohol. Endogenous peroxidase
was blocked with 3% hydrogen peroxide. Antigen retrieval was
achieved by microwave using EDTA buffer (pH 9.0). Sections
were then incubated overnight at 4uC with a monoclonal antibody
mouse a-SMA (1:800 dilution, Santa Cruz, California, USA). The
antibody binding was detected with an Envision
TM Detection Kit,
Peroxidase/DAB, Rabbit/Mouse (Gene Tech, Shanghai, China).
Then the sections were counterstained with haematoxylin. For
negative control, the buffer replaced the primary antibody. The
positive areas stained with a-SMA was examined in all specimens
using a microscope (CTR 6000; Leica, Wetzlar, Germany) and
analyzed by using image analysis software (Image Pro Plus soft-
ware, Media Cybernetics, Gleichen, Germany).
Immunofluorescence staining of a-SMA and collagen 1a1
Paraffin-embedded pancreas samples were deparaffinized and
rehydrated. Sections were microwave treated (565 minutes) in
EDTA buffer (pH 9.0), allowed to cool for 30 minutes, and
washed in PBS (365 minutes). After being blocked for 20 minutes
with 5% bovine serum albumin, slides were incubated overnight at
4uC with a mouse monoclonal antibody against a-SMA (1:200
Figure 1. Schematic map of the experimental design. Four
groups of rats (n=10) were studied. Groups a and b received saline
injections (no induction of chronic pancreatitis), groups c and d
received TNBS injections (0.4 ml of 2% TNBS for the induction of chronic
pancreatitis). Groups a and c received normal chow throughout the
entire 8-week study period. Groups b and d received chow mixed with
2% L-cysteine during the 8-week study, after which the rats were
sacrificed. Arrows indicate injections with TNBS.
doi:10.1371/journal.pone.0031807.g001
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(1:50 dilution). Sections were then rinsed in PBST (PBS+0.1%
Tween-20) and immunoreactive protein was detected using a
donkey anti-mouse antibody (1:400 dilution) conjugated with
fluorochrome Cy3 (Jackson ImmunoResearch Laboratory, USA)
and a donkey anti-rabbit antibody (1:200 dilution) conjugated
with fluorochrome Alexa FluorH 488 (Jackson ImmunoResearch
Laboratory, USA) for 1 h in the dark. After being rinsed in PBST,
slides were mounted with Fluoromount
TM mounting medium
(Sigma-Aldrich, St. Louis, Missouri, USA) with 49, 6-diamidino-2-
phenylindole (DAPI) (1:1000 dilution). Fluorescence analysis was
performed by using a confocal laser scanning microscope (LSM
710; Zeiss, Germany) and Zen 2009 software (Carl-Zeiss, Jena,
Germany).
Hydroxyproline assay
Intrapancreatic hydroxyproline was quantified using the
detection kit according to Reddy and Enwemeka [21] and the
manufacturer’s instructions (Jiancheng Bioengineering Institute,
Nanjing, China). Hydroxyproline content is expressed as micro-
grams of hydroxyproline per gram pancreatic tissue.
Cell culture and immunocytochemistry of
bromodeoxyuridine (BrdU)
PSCs were isolated from pancreas by the method described by
Apte et al [22]. Freshly isolated rat PSCs were seeded on 1-cm
2
uncoated glass coverslips in 6-well plates (10 cm
2/well; two to
three glass coverslips per well) and cultivated in DMEM/F12
(Gibco BRL, USA) supplemented with 10% fetal bovine serum
(FBS; Gibco BRL, USA) and 1% penicillin–streptomycin (Gibco
BRL, USA) at 37uC, 5% CO2. On the next day, the culture
medium was changed to MEM+0–10 mM L-cysteine. After a 3-
day exposure to L-cysteine, some coverslips were treated with
10 mM Brdu (Sigma-Aldrich, St. Louis, Missouri, USA) and fixed
in 4% paraformaldehyde. After 5-day exposure to L-cysteine, the
other coverslips were fixed in 4% paraformaldehyde. Then cells
were immunostained for Brdu and a-SMA essentially as described
above for tissue sections.
Effect of L-cysteine on acinar cells’ viability
Acinar cells were isolated according to the procedure described
by Hu et al [23–25]. Acinar cells (5610
4/well) were seeded in 24-
well plates in DMEM/F12 supplemented with 10% FBS and 1%
penicillin–streptomycin at 37uC, 5% CO2. 24 hours later, the cells
were treated with MEM+0–10 mM L-cysteine and incubated for
3 days. Cell viability was determined by Cell Counting Kit-8
(Dojindo, Kumamoto, Japan) according to manufacturer’s in-
struction.
Cell cycle analysis by flow cytometry
When 30% confluence was achieved, PSCs were synchronized
for 24 h with 0.4 mg/ml Demecolcine (Sigma-Aldrich, St. Louis,
Missouri, USA) and treated with 0–1 mM L-cysteine, After 3 days,
the cells were collected with trypsin, washed 3 times with PBS, and
fixed in 70% ethanol at 4uC. The cells were then suspended in a
solution containing Nonidet P-40 and ribonuclease A and, after
staining with 0.5 mg/ml propidium iodine, S-phase fractions and
cell-cycle kinetics were carried out using a FACS Calibur (Becton
Dickinson,San Jose, CA) using CELL Quest version 3.3 software.
Oxidative stress analysis
The levels of malondialdehyde (MDA) and 4-hydroxynonenal
(4-HNE) in fresh pancreatic tissues and PSCs were measured to
assess lipid peroxidation, using LPO-586 commercial kit (ENZO
Life Sciences, Inc., Farmingdale, NY), according to the manufac-
turer’s protocol. MDA+4-HNE levels were measured spectropho-
tometrically and were measured in triplicate.
Glutathione (GSH) concentrations were estimated in the pancreas
samples and PSCs using Total Glutathione Quantification Kit
(Dojindo Molecular Technologies Inc, Kunamoto, Japan) according
to the manufacturer’s protocol.
Protein concentration was determined by the standard BCA
method (BCA
TM Protein Assay Kit, Pierce, USA).
Real Time Quantitative PCR (qRT-PCR)
Total RNA was isolated from pancreas of CP rats using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA) and then quantified. RT
reactions were performed with total RNA (2 mg) according to the
ExScript RT reagent kit. qRT-PCR was performed in triplicate for
each gene of interest under each triplicate experimental condition
using ABI Prism 7900HT Sequence Detection System (Applied
Biosystems, CA, USA). GAPDH was used as separate endogenous
controlstowhich eachgeneof interestwas normalized. Fold changes
and subsequent percent gene expression levels relative to designated
control groups were calculated using the comparative CT (2
2DDCT)
method. The primer sequences are as follows: Nuclear erythroid-
related factor 2 (Nrf2) (109 bp), forward: 59-GCTATTTTCCAT-
TCCCGAGTTAC-39,r e v e r s e :5 9-ATTGCTGTCCATCTCTGT-
CAG-39. NAD(P)H: quinine oxidoreductase-1 (NQO1) (197 bp),
forward: 59-CATCATTTGGGCAAGTCC-39,r e v e r s e :5 9-ACAG-
CCGTGGCAGAACTA-39. Heme oxidase-1 (HO-1) (102 bp), for-
ward: 59-CTTTCAGAAGGGTCAGGTGTC-39,r e v e r s e :5 9-TG-
CTTGTTTCGCTCTATCTCC-39. IL-1b (131 bp), forward: 59-
TGTGATGTTCCCATTAGAC-39,r e v e r s e :5 9-AATACCACTT-
GTTGGCTTA-39. GAPDH (140 bp) forward: 59-TATCGGACG-
CCTGGTTAC-39,r e v e r s e :5 9-CTGTGCCGTTGAACTTGC-39.
Western blot analysis
For western blot analysis, murine pancreas was rapidly ground in
liquid nitrogen. The resulting powder was reconstituted in ice-
cold RIPA buffer containing 1 mM phenylmethanesulfonyl fluor-
ide(PMSF) and a cocktail of protease inhibitors (1:100 dilution;
Sigma-Aldrich). Primarily isolated PSCs treated with 0 mM-
10 mM L-cysteine for 5 days were rinsed twice in PBS, then lysed
for 2 h in RIPA lysis buffer on ice. After centrifuging the homo-
genates at 20,000 g for 10 minutes at 4uC, protein concentrations
were determined. Equal amounts of protein (20 mg from cells or
40 mg from tissues) were electrophoresed through sodium dodecyl
sulfate/polyacrylamide gels (Bio-Rad, California, USA) and trans-
ferred electrophoretically to membranes. Nonspecific binding was
blockedby1 hincubationofthemembranein5%low-fatmilk.The
blots were then incubated with a primary antibody overnight at
4uC. Following incubation with peroxidase-conjugated secondary
antibodies, proteins were visualized using the ECL-detection system
(Santa Cruz Biotechnology, Santa Cruz, CA), quickly dried, and
exposed to ECL film.
Primary antibodies were as follows: anti-a-SMA (1:250 dilution;
Santa Cruz Biotechnology, Santa Cruz, CA), anti-transforming
growth factor-b1( T G F - b1) (1:250 dilution; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), anti-collagen 1a1 (1:250 dilution; Santa Cruz
Biotechnology), anti-GAPDH (1:1,000 dilution; Epitomics), anti-
tissue inhibitors of metalloproteinase 1 (TIMP1) (1:100 dilution;
Santa Cruz Biotechnology), anti-matrix metalloproteinase 2 (MMP2)
(1:100 dilution; Santa Cruz Biotechnology), anti-interleukin-1b (IL-
1b) (1:200 dilution; Santa Cruz Biotechnology), anti-PDGFRb (1:200
dilution; Cell Signaling Technology;Danvers, MA, USA) and
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Cruz, CA).
Statistical analysis
Data are presented as the mean6standard deviation (SD).
Statistical analysis was performed using one-way analysis of
variance (ANOVA) followed by SNK tests as a post hoc test.
The Kruskal-Wallis test was used to evaluate the differences
in categorical values followed by Mann-Whitney U tests as
a post hoc test. p value of ,0.05 was accepted as statistically
significant.
Results
Effects of L-cysteine on serum indexes, body weight
L-cysteine showed no effects on serum amylase, lipase and body
weight changes both in control groups and TNBS treated groups
(Figures S1, S2).
L-cysteine had no side effect on important organs and on
viability of primarily isolated acinar cells
In vitro study showed that there was no obvious morphological
difference between acinar cells treated with or without L-cystein
for 3 days (Fig. S3A, S3B) and the viability of acinar cells was not
affected by L-cysteine administration (Fig. S3C).
In addition, in vivo study showed that there were not obvious
histological changes in lung, liver, intestine, kidney between group
c and group d (Fig. S4).
L-cysteine attenuated chronic pancreatitis in rats induced
by TNBS
Two months feeding of L-cysteine showed no significant
histological changes between sham groups (groups a and b),
indicating a long term treatment with L-cysteine was not toxic to
the normal pancreas by tissue section observations. In TNBS
treated rats (groups c and d), there were histopathological signs of
chronic pancreatitis at the time of sacrifice (week 8), as reflected by
abnormal architecture, glandular atrophy, pseudotubular com-
plexes, fibrosis, and inflammatory cell infiltrates (Table 1 and
Figure 2; all p,0.05 for the comparisons with groups a and b). L-
cysteine administration (group d) led to less severe pancreatic
damage in CP rats in terms of all the evaluating scores mentioned
above (Table 1 and Figure 2; all p,0.05 for the comparisons with
group c).
L-cysteine prevented fibrosis in pancreatic tissue
To evaluate the degree of fibrosis in the pancreas, Masson-
stained pancreas sections were analyzed using computer-assisted
digital image analysis. Pancreatic collagen content dramatically
increased after induction of CP (Figure 3A–C). However, the
increase in pancreatic collagen content was diminished by L-
cysteine feeding (Figure 3A–D). Positive areas of Masson-stained
sections of group c were higher compared with group a (Figure 3C,
2.4160.66 vs. 28.6364.91%; p,0.01 group a vs. group c). 2.0%
L-cysteine diet (group d) decreased the positive areas of Masson-
stained sections compared with group c (Figure 3C, 28.6364.91%
vs. 15.3664.55%; p,0.01 group c vs. group d).
Immunohistochemistry (IHC) of a-SMA was performed to
quantify the number of activated stellate cells, the expression of
which was obviously increased during TNBS-induced pancreatitis
and reduced by L-cysteine treatment (Figure 3B). Positive areas
of a-SMA-stained sections were higher in group c than that in
group a (Figure 3D, 30.3167.69% vs. 2.5560.69%; p,0.01). A
2.0% L-cysteine diet (group d) decreased the positive areas of a-
SMA-stained sections (Figure 3D, 30.3167.69% vs. 3.5261.65%;
p,0.01).
A marked decrease in pancreas wet weight secondary to
pancreatic atrophy after chronic injury, was noted in group
c (Figure 3E, 2.6460.51 mg/g body weight) compare with group
a (Figure 3E, 11.2161.96 mg/g body weight) and b (10.866
0.59 mg/g body weight) and were significantly attenuated in
group d (Figure 3E, 5.906.07 mg/g body weight), which included
supplementation with 2% L-cysteine.
For further confirmation of the anti-fibrotic role of L-cysteine in
CP rats, the content of hydroxyproline in the pancreas was also
assayed, which was significantly increased to (732.84648.93) mg/g
wet weight in group c on day 28 compared with group a (191.506
38.25 mg/g wet weight) and group b (185.85636.66 mg/g wet
Figure 2. Histological observations in H&E stained sections. For the description of groups a to d, see Figure 1. Abnormal architecture,
glandular atrophy, pseudotubular complexes, fibrosis and inflammatory cell infiltration can be seen in group c, while appearance is fairly normal in
groups a and b. Representative H&E sections of rats revealed that 2% L-cysteine attenuated the development of pancreatic fibrosis induced by TNBS
(group d). Representative original magnification 6200.
doi:10.1371/journal.pone.0031807.g002
Table 1. L-cysteine reduces the severity of experimental
chronic pancreatitis.
ab c d
Glandular
atrophy
0600 60 2.1060.18
# 1.5060.16
#
Fibrosis 0600 60 2.5060.17
# 1.2060.20
**#
Inflammation 0600 60 2.3060.21
# 1.4060.22
*#
Damage
index(DI)
0600 60 6.9060.35
# 4.1060.35
**#
For the description of the histopathological score, see the Materials and
Methods section. Data were expressed as mean6SD (n=10). A Mann-Whitney
U test was used to evaluate the differences among the groups. Chronic
pancreatitis groups showed pancreatic fibrosis and damage (
#p,0.01 vs.
groups a and b). L-cysteine administration alleviated pancreatic fibrosis
(*p,0.05 vs. group c, **p,0.01 vs. group c).
doi:10.1371/journal.pone.0031807.t001
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tissue sections stained with Masson and stained immunohistochemically for a-SMA. (C, D) Quantification of the positive areas of Masson and a-SMA
by Image Pro Plus. (E) Effect of L-cysteine treatment on pancreas wet weight. Pancreas wet weight was significantly increased in L-cysteine treated
rats. (F) Effect of L-cysteine treatment on pancreatic content of hydroxyproline after TNBS injury. Values are mean6SD (n=10). Significant differences:
**p,0.01 group c vs. group d. Representative original magnification 6200.
doi:10.1371/journal.pone.0031807.g003
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wet weight (Figure 3F), showing a tendency of reduction by L-
cysteine in the accumulation of collagens in the pancreas of CP rats.
To confirm the presence of PSCs in fibrotic areas immunoflu-
orescence staining of a-SMA and collagen 1a1 was conducted
(Figure 4A). In normal pancreas collagen 1a1 appeared as loose
fibres surrounding acinar units and pancreatic islets. Intense
immunostaining for a-SMA was found in cells of vessels located
within interlobular septa, while cells of pancreatic lobules showed
no staining. In CP rats intense immunostaining for collagen 1a1
was present in the fibrous septa and in the fibrotic stroma
surrounding pancreatic acini. The deposition of collagen 1a1 was
markedly enhanced in comparison to normal tissues. Meanwhile
the number of cells expressing a-SMA was increased in the fibrotic
tissue, particularly in the connective tissue surrounding fibrotic
acini and at the interface between fibrotic septa and lobules. L-
cysteine administration led to less expression of a-SMA and
collagen 1a1. A same tendency was shown in the analysis for
positive areas of collagen 1a1-stained sections (Figure 4B).
Along with the IHC assay, the expression of collagen deposition
related proteins and cytokines, including a-SMA, TIMP1, TGF-
b1 and IL-1b, increased significantly after TNBS treatment
compared with normal rats and decreased obviously after L-
cysteine administration as shown in Figure 4C and 4D. An
opposite tendency was observed in the expression of MMP2.
L-cysteine inhibited the proliferation and activation of
PSCs in vitro
To evaluate whether L-cysteine affected the proliferation of
activated PSCs in vitro, BrdU incorporation into the nucleus of
Figure 4. L-cysteine modulates extracellular matrix secretion in vitro. For the description of groups a to d, see Figure 1. (A, B) Double
immunofluorescence of collagen 1a1 (green) and a-SMA (red) in the pancreas, 49, 6-Diamidino-2-phenylindole (DAPI; blue) was used to counterstain
nuclei. The co-localization of collagen 1a1 and a-SMA is highlighted by the yellow color. Immunostainning showed a low expression of collagen 1a1
in the sham pancreas, but its expression increased obviously after 4 weeks TNBS treatment, while L-cysteine administration attenuated collagen 1a1
expression in CP rats. (C, D) Expression of a-SMA, MMP2, TIMP1, TGF-b1 and IL-1b proteins in 4 groups of pancreatic tissues were detected by western
blot analysis. GAPDH was used as the loading control in all experiments. The results were quantified by determining the intensities of the bands
compared with those of GAPDH. All data are presented as the mean6SD of three independent experiments. Significant differences: *p,0.05 vs.
group c, **p,0.01 vs. group c. Representative original magnification 6400.
doi:10.1371/journal.pone.0031807.g004
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cysteine showed a concentration-dependent manner (Figure 5A).
Inhibition of BrdU incorporation was first seen at 1 mM L-
cysteine. There was a significant reduction in proliferation rates
when the culture media was supplemented with 10 mM L-
cysteine. a-SMA was characterized as a marker of PSC activation
and its expression was decreased by L-cysteine, and it was
especially inhibited by 10 mM L-cysteine (Figure 5B). The cell
cycle distribution was analyzed by flow cytometry. Compared with
10% FBS alone, L-cysteine decreased the percentage of cells in
G0/G1 and increased the percentage of cells in G2/M phase in a
concentration-dependent manner (Figure 5C). Western blot
analysis revealed that the expression of PDGFRb, TGFbRII,
collagen 1a1 and a-SMA in PSCs was suppressed by supplemen-
tation with L-cysteine, especially at 10 mM (Figure 5D).
Oxidative stress analysis
MDA+4-HNE levels and GSH concentrations in pancreatic
tissues and PSCs were analyzed to determine the oxidative stress
status (Figure 6). The contents of MDA+4-HNE in pancreatic
Figure 5. L-cysteine inhibits the proliferation and activation of PSCs. (A) Brdu staining of PSCs three days after L-cysteine treatment, DNA
synthesis was detected by BrdU incorporation during the final 2 hours (dividing cells are stained dark brown). (B) Effect of L-cysteine on the activation
of freshly isolated PSCs. After culturing PSCs isolated from a rat for 24 hour, the medium was changed to MEM+0–10 mM L-cysteine. PSCs were
cultured for five days under the above conditions and a-SMA expression by PSCs was measured with immunocytochemistry. (C) The cell cycle
distribution of PSCs at different concentrations of L-cysteine was analyzed by flow cytometry. (D) Expression of PDGFRb, TGFbRII, a-SMA and collagen
1a1 protein in the PSCs treated with different concentrations of L-cysteine was analyzed by western blot. GAPDH was used as a loading control. The
intensities of bands were measured, and the represented values correspond to the PDGFRb, TGFbRII, a-SMA and collagen 1a1/GAPDH ratio. All data
are presented as the mean6SD of three independent experiments. Significant differences: *p,0.05 vs. control group, **p,0.01 vs. control group.
Representative original magnification 6200.
doi:10.1371/journal.pone.0031807.g005
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compared with sham group, but decreased obviously after L-
cysteine administration (p,0.01 group c vs. group d). The total
GSH levels in pancreatic tissues were found lower in TNBS treated
group compared with the sham control group and L-cysteine
treatment significantly increased the GSH levels compared with
those in group c (p,0.01 group c vs. group d). Similarly, a dose-
dependent change of the levels of MDA+4-HNE and GSH could be
seen in PSCs in vitro after L-cysteine treatment.
Effect of L-cysteine on Nrf2 expression and its regulated
genes in pancreas of CP rats
To determine whether Nrf2 and Nrf2 regulated genes could be
induced by L-cysteine in CP rats, mRNA expression of Nrf2, NQO1,
HO-1, and IL-1b was determined by qRT-PCR. mRNA expression
of Nrf2 in rats of group c was low compared with it of sham groups
(Fig. 6E). However, its mRNA expression increased after L-cysteine
administration (P,0.01). In addition, mRNA expression of NQO1
Figure 6. L-cysteine modulates oxidative stress in vitro and in vivo and regulates Nrf2 associated pathway. For the description of groups
a to d, see Figure 1. (A) MDA+4HNE concentration of pancreatic tissues. MDA+4HNE concentration of pancreatic tissues increased significantly after
induction of CP compared with sham groups and decreased obviously after L-cysteine administration. (C) GSH levels of pancreatic tissues. GSH levels
of pancreatic tissues decrease significantly after TNBS administration compared with sham groups and increased obviously after L-cysteine
administration. (B, D) In vitro study, L-cysteine treatment affected MDA+4-HNE and GSH levels in a dose-dependent manner in PSCs as that in in vivo
study. (E) Relative mRNA levels of Nrf2, NQO1, HO-1 and IL-1b after L-cysteine treatment in pancreas of four groups. All data are presented as the
mean6SD of three independent experiments. Significant differences: *p,0.05 vs. group c, **p,0.01 vs. group c, # p,0.05 vs. control group,
## p,0.01 vs. control group.
doi:10.1371/journal.pone.0031807.g006
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compared with group c while IL-1b had an opposite tendency.
Discussion
Girish and colleagues observed significant reduction in plasma
sulphur containing amino acids, such as methionine and cystine, in
patients with chronic pancreatitis, suggesting the potential role of
these amino acids in the pathogenesis of this disease [26]. Horie et
al. showed that L-cysteine is effectively against liver fibrosis. The
mechanism of inhibition of fibrosis in the liver was suggested to
be the direct inhibition of activated Hepatic stellate cell (HSC)
proliferation and HSC transformation by L-cysteine [18]. Matsui
et al. found that L-cysteine and L-methionine regulated the
activation of HSCs. Their oral intake aided suppression of the
progression of liver fibrosis [27]. As PSCs share homologies with
HSCs [28], our current results demonstrated that L-cysteine
treatment also attenuated pancreatic fibrosis in CP rats.
The TNBS model exhibited morphological changes mimicking
features of chronic pancreatitis in humans in TNBS treated rats
[19,20]. In our study, the pancreatic content of hydroxyproline
was reduced by L-cysteine treatment and, histologically, H&E,
Masson and a-SMA staining showed less pancreatic fibrosis in the
L-cysteine treated group. Also, we demonstrated marked changes
of the collagen deposition correlative protein. These findings
indicated that pancreatic fibrosis induced by TNBS may be
attenuated by L-cysteine administration.
In this model, PSCs activation was associated with fibrosis and
activated PSCs were the main cellular source of collagen in CP [9].
In our study, an L-cysteine diet decreased the positive areas of a-
SMA-stained sections compared with group treated with normal
chow. This finding showed that L-cysteine may inhibit pancreatic
fibrosis through inhibiting activation of PSCs. Analysis using
primary-cultured PSCs revealed that this amino acid attenuated
PSCs activation and proliferation, and the expression of PDGFRb,
TGFbRII, collagen 1a1 and a-SMA. This result is in line with
Hiroko Matsui’s result [27]. Reports showed that the proliferation
of PSCs is associated with PDGF-ERK pathway, whereas the
extracellular cell matrix(ECM) production of PSCs is associated
with TGF-b related pathway [29–33]. Hence, the implication is
that the beneficial effects of L-cysteine administration may be
produced mainly by suppressing the proliferation and ECM
production of PSCs through down-regulating the receptors of the
two pathways mentioned above.
Molecular mechanisms for L-cysteine inhibiting fibrosis in vivo
may be derived from its potential as a reducing agent in body
metabolism. L-cysteine is utilized in the synthesis of proteins, non-
protein compounds including taurine, reduced inorganic sulfur,
sulfate, and GSH [15]. The major factors regulating GSH bio-
synthesis are the availability of cysteine [34–36]. Oxidative stress
has been demonstrated to play an important role in the path-
ogenesis and progression of pancreatitis and also contributes to the
development of pancreatic fibrosis [37–44]. Our current study
showed that L-cysteine reduced the levels of MDA+4-HNE and
enhanced the content of GSH in pancreatic tissues and PSCs,
indicating its antioxidant effect which would ameliorate pancreatic
fibrosis.
Another plausible reason is that L-cysteine may inhibit
pancreatic fibrosis through modulating ECM deposition. A
distorted balance of extracellular matrix synthesis and degradation
in chronic pancreatitis is reported by several papers [1,32,45]. As
mentioned before, PSCs have been shown to modulate the balance
of extracellular matrix secretion and digestion by producing
matrix metalloproteinases (MMPs) and their corresponding
inhibitors, tissue inhibitors of metalloproteinases (TIMPs) [46].
In our study we observed an increase of MMP2 levels and a
decrease of TIMP1 levels after treatment with L-cysteine which
would reduce collagen synthesis. These findings show that L-
cysteine may inhibit pancreatic fibrosis through modulating ECM
deposition.
In addition, western blot analysis indicated that L-cysteine
significantly down-regulated expression of TGF-b and IL-1bin CP
rats, both of which are pivotal profibrotic cytokines as confirmed
by several reports [13,29,47,48]. By Stimulating the synthesis
and secretion of collagens of PSCs, TGF-b promotes collagen
deposition [29,49,50]. IL-1b has also been shown to have an
important role in the pathogenesis of pancreatitis [48,51]. IL-1b is
a well described activator of pancreatic stellate cells [47]. Both
TGF-b receptor knockout mice and IL-1b over-expression mice
consistently develop severe chronic pancreatitis [51,52]. Our
results suggested that L-cysteine may inhibit pancreatic fibrosis
through modulating inflammatory cytokine.
Recently, Nrf2 has emerged as an indispensable regulator of
the constitutively inducible cytoprotective genes in various tissues
and cell types [53–55]. In response to oxidative stress, Nrf2
accumulates in the nucleus, where it binds to Antioxidant
Response Element (ARE) sequences in the regulatory sequences
of its target genes which encode antioxidant enzymes and de-
toxifying proteins [56,57]. For further investigation into the
mechanism by which L-cysteine enhances antioxidant activity we
observed the effect of L-cysteine on expression of Nrf2 and its
downstream phase II antioxidant enzyme genes NQO1 and HO-
1. Our study demonstrated that L-cysteine increased the mRNA
expression of Nrf2 and its downstream genes NQO1 and HO-1
which enhance antioxidant defense capacity. Also, L-cysteine
decreased the mRNA expression of IL-1b which in line with some
reports using Nrf2 knock-out mice that showed increased
expression of the inflammatory cytokine IL-1b compared with
wide type mice [58,59]. Thus, the results suggested that the
increase of Nrf2 may be a plausible mechanism by which L-
cysteine enhances antioxidant effect and modulates inflammatory
cytokine.
It is worthwhile mentioning that L-cysteine was administered
prior to the induction of CP, which does not simulate a clinical
situation. Therefore, experiments should be established to study
whether L-cysteine is even beneficial in a therapeutic setting when
given after initial damage.
In summary, L-cysteine has an anti-fibrotic effect on chronic
pancreatitis induced by TNBS through inhibiting the activation
and proliferation of PSCs and may be served as therapeutic
potential agent for the treatment of pancreatic fibrosis. With PSCs
as a star on the rise in pancreatic disease research [60], L-cysteine
may also be considered as a potential inhibitor of PSCs in the
future.
Supporting Information
Figure S1 Body weight of the CP rats. We weighed the
body weight of the rats in the 4 groups during the entire study to
observe the effect of L-cysteine on nutrition. There were no
obvious changes among the four groups.
(TIF)
Figure S2 Serum amylase and lipase activity. Serum
amylase and lipase activity were measured in the 4 groups des-
cribed above 4 weeks after TNBS injection. There were no sig-
nificant changes among the four groups.
(TIF)
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viability of acinar cells. Primary isolated acinar cells cultured
in DMEM/F12+10%FBS (6200). (B) Acinar cells cultured with L-
cysteine for 3 days (at 10 mM,6200). (C) Acinar cells were treated
with increasing doses of L-cysteine for 3 days and cell viability was
determined by CCK-8 kit.
(TIF)
Figure S4 Histological observations in H&E stained
sections of rat organs. Representative H&E sections of rat
lung (A), liver (B), intestine (C) and kidney (D) revealed that there
are not obviously histological changes compared with group c after
a long term administration of L-cysteine (group d). Representative
original magnification 6200.
(TIF)
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